MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report
News ResearchAnswer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...
-
No one left behind: generational transfer of knowledge as essential for universal quality treatment
Interview Medicine Equality Now!In Kazakhstan, many people living with HIV waited for years to access treatment with old generation antiretrovirals (ARVs). These medicines...
-
Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
Interview Medicine Equality Now! NewsMMA’s campaign partner in Kazakhstan, Answer, focuses on reducing prices, and improving access to optimal treatment for HCV, viral hepatitis...
Read more about Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
-
Russian Federation’s updated patent law puts public health first
NewsThe Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...
Read more about Russian Federation’s updated patent law puts public health first
-
GALLERY: International Women’s Day 2021
News Photo galleryAround this time last year, before many countries went into their first COVID-19 related lockdown, Make Medicines Affordable met with...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
News Press releaseDolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
